Conversations: Fireside Video Chats
The “Conversations” video series will feature virtual fireside chats with neuroscience experts who will discuss advances in the research and treatment of Alzheimer’s disease, dementia with Lewy bodies (DLB), and other age-related neurodegenerative conditions.
Please note, our podcast series does not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately.
Episode 10: Studying the Patient-Caregiver Lived Experience in Dementia with Lewy Bodies
| Featuring: | |
| Brendan Kelley, MD (moderator) UT Southwestern Medical Center | Professor and Clinical Vice Chair in the Department of Neurology |
| Samantha K. Holden, MD, MS, FAAN University of Colorado School of Medicine | Associate Professor of Neurology, Vice Chair for Outpatient Neurology Services |
| Carla Preyer Salon Owner, Inspirational Speaker | Care Partner to her Husband, Patrick |
| Linda Szypula Ed.D. Science Teacher | Care Partner to her Husband, James |
| Index: | |
| 0:00 | Introduction |
| 2:00 | Caregiver Distress and Symptom Burden |
| 16:14 | Measuring Meaningful Changes in a Clinical Trial |
| 22:09 | Closing remarks |
share this video
Episode 9: Executing Clinical Research in Dementia with Lewy Bodies (DLB)
| Featuring: | |
| Anthony Caggiano, M.D., Ph.D. (moderator) Cognition Therapeutics | Chief Medical Officer |
| James E. Galvin, MD, MPH. University of Miami | Director of the Comprehensive Center for Brain Health, Miller School of Medicine |
| Lawrence S. Honig, MD, PhD, FAAN Columbia University | Professor of Neurology, Irving Medical Center |
| David Shprecher, D.O. Banner Sun Health Research Institute | Movement Disorder Director, Banner Sun Health Clinical Associate Professor, University of Arizona |
| Index: | |
| 0:00 | Introduction |
| 0:45 | Comparing Alzheimer’s disease and DLB |
| 5:02 | SHIMMER Design and Outcomes |
| 10:22 | Metrics for Success in a Signal-finding Study |
share this video
Episode 8: Protecting the Synapse from Amyloid Toxicity in Alzheimer’s Disease
| Featuring: | |
| Anthony Caggiano, M.D., Ph.D. (moderator) Cognition Therapeutics |
Chief Medical Officer |
| Mary Hamby, Ph.D. (moderator) Cognition Therapeutics |
Vice President of Research |
| Everard (Jort) Vijverberg, MD, PhD Alzheimer Center at Amsterdam University Medical Center |
Neurologist and CNS Trial Specialist |
| Tara Spires Jones, DPhil University of Edinburgh |
Personal Chair of Neurodegeneration and Deputy Director of the Centre for Discovery Brain Sciences |
| Index: | |
| 0:00 | Introduction |
| 3:49 | Findings from SEQUEL |
| 6:45 | Clinical observations of CT1812 engagement |
| 9:08 | Proteomic evidence of CT1812 engagement |
| 11:52 | CT1812’s ongoing Phase 2 study |
share this video